Zecotek Grants Stock Options
Vancouver, January 15, 2007 – Zecotek Medical Systems Inc. (TSX-Venture – ZMS; Frankfurt- W1I.F) announces the granting of 160,000 stock options to Directors and employees for their contributions to the Company. The exercise price is set at $0.80 and will expire on January 15, 2012. The stock options are subject to regulatory approval.
Zecotek Medical Systems is a bio-photonics technology company developing high-performance crystals, photo detectors, medical lasers, optical imaging and 3D display technologies for commercial applications in the medical diagnostics and high-tech industry. Founded in 2003, the company has three distinct operating divisions: medical imaging, medical lasers and 3D display and labs located in Canada, Singapore and Russia. Zecotek commercialises its novel, patented and patent-pending bio-photonic technologies directly and through strategic alliances and joint ventures with multinational OEMs, distributors and other industry leaders.
For additional information on Zecotek Medical Systems and our technologies please see our website at Zecotek Photonics.
For additional information please contact:
Zecotek Medical Systems
CFO; VP Corporate Development
The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future, please email email@example.com and mention ZMS News in the subject heading or visit the corporate website at www.zecotek.com